BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/15/2023 3:41:16 PM | Browse: 195 | Download: 451
 |
Received |
|
2022-10-27 14:31 |
|
Peer-Review Started |
|
2022-10-27 14:33 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-12-26 08:30 |
|
Revised |
|
2022-12-27 12:28 |
|
Second Decision |
|
2023-02-10 03:37 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-02-10 18:18 |
|
Articles in Press |
|
2023-02-10 18:18 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-03-09 10:36 |
|
Publish the Manuscript Online |
|
2023-03-15 15:41 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Biology |
| Manuscript Type |
Minireviews |
| Article Title |
Carbamylated lipoproteins in diabetes
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Damien Denimal |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Damien Denimal, PharmD, PhD, Assistant Professor, Department of Biochemistry, University Hospital of Dijon, 2 rue Ducoudray, BP 37013, Dijon 21079, France. damien.denimal@u-bourgogne.fr |
| Key Words |
Carbamylation; Lipoprotein; Diabetes; Low-density lipoprotein; High-density lipoprotein; Myeloperoxidase |
| Core Tip |
There is growing evidence that carbamylation of lipoproteins occurring in diabetes contributes to the pathophysiology of atherosclerosis, and therefore plays a role in the cardiovascular risk. Numerous studies have demonstrated that carbamylated low-density lipoproteins (LDL) is more atherogenic than native LDL, citing, for instance, its role in foam cell formation or ability to damage endothelial function. In addition, carbamylated high-density lipoproteins exhibits reduced antiatherogenic properties, especially in terms of the capacity to induce cholesterol efflux from macrophages and to protect endothelium. |
| Publish Date |
2023-03-15 15:41 |
| Citation |
<p>Denimal D. Carbamylated lipoproteins in diabetes. <i>World J Diabetes</i> 2024; In press</p> |
| URL |
https://www.wjgnet.com/1948-9358/full/v14/i3/159.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v14.i3.159 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
